A case of measles in a Nepalese child: where are we failing?

Authors

  • Nimesh Lageju B.P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Durga Neupane B.P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Lokesh Shekher Jaiswal Department of Surgery (Division of CTVS), B. P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Ashish Kumar Jha B.P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Roshan Rawat B.P. Koirala Institute of Health Sciences, Dharan, Nepal

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20220878

Keywords:

Measles, Nepal, Children

Abstract

Measles affected more than 90% of children under 15 years of age and caused 2-3 million measles-associated deaths globally each year before the introduction of vaccines against it. Today, measles vestiges a leading cause of vaccine-preventable illness worldwide, causing more than 100,000 deaths annually. Characterized by a febrile rash illness, measles is often self-resolving. However, significant complications can occur including encephalitis with permanent neurologic sequelae and death in one to three out of 1000 measles cases. Although global measles elimination is a WHO goal, current trends in the epidemiology of measles and vaccine hesitancy suggest that this goal is not yet attainable. As the most highly transmissible vaccine-preventable disease, measles is especially subtle to changes in herd immunity, the impact of vaccine refusal and globalization.

Metrics

Metrics Loading ...

References

Paules CI, Marston HD, Fauci AS. Measles in 2019 going backward. N Engl J Med. 2019; 380:2185-7.

Hayman DTS. Measles vaccination in an increasingly immunized and developed world. Hum Vacc Immunother. 2019;15:28-33.

Graham M, Winter AK, Ferrari M. Measles and the canonical path to elimination. Science. 2019;364:584-7.

Feemster KA, Szipszky C. Resurgence of measles in the United States: how did we get here? Curr Opin Pediatr. 2020;32(1):139-44.

Gao Y, Kc A, Chen C, Huang Y, Wang Y, Zou S, Zhou H. Inequality in measles vaccination coverage in the "big six" countries of the WHO South-East Asia region. Hum Vaccin Immunother. 2020;16(7):1485-97.

Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, et al. Progress toward regional measles elimination Worldwide, 2000-2018. MMWR. 2019;68(48):1105-11.

WHO South-East Asia regional immunization technical advisory group. Available at: WHO South-East Asia Regional Immunization Technical Advisory Group (‎SEAR-ITAG)‎: Report of the Ninth Meeting. Accessed on 20 September 2021.

Hyle EP, Fields NF, Fiebelkorn AP. The clinical impact and cost & effectiveness of measles mumps rubella vaccination to prevent measles importations among international travelers from the United States. Clin Infect Dis. 2019;69:306-15.

Downloads

Published

2022-03-25

How to Cite

Lageju, N., Neupane, D., Jaiswal, L. S., Jha, A. K., & Rawat, R. (2022). A case of measles in a Nepalese child: where are we failing?. International Journal Of Community Medicine And Public Health, 9(4), 1937–1938. https://doi.org/10.18203/2394-6040.ijcmph20220878

Issue

Section

Letter to the Editor